All In Biotech

Drug Trial Radar · NCT06541847

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

A Phase 2, Open-Label, Single Arm, Non-Controlled, Single-Stage Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Plexiform Neurofibroma and Neurofibromatosis Type 1

Last checked: Nov 19, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

25

Planned (sponsor's estimate)

Start

Feb 10, 2025

Primary completion

Jun 2027

Study completion Jan 2028

Sponsor

Lead sponsor
Healx LimitedIndustry
Sponsor type
Industry
First posted
Aug 7, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The trial will be an open label, single arm, phase 2 study to assess the tolerability and efficacy of HLX-1502 in participants with NF1 that are 16 years or older in age with progressive and/or symptomatic PN. This study will also investigate the safety and efficacy of HLX-1502 in a small cohort of 12 to 15 year olds.

Conditions

  • Neurofibromatosis Type 1

Interventions

  • HLX-1502Drug

    Participants will take an oral dose three times a day (with or without food) for up to 24 cycles (a cycle is defined as 28 days).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. PN response rateTime frame: 12 months

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama · Recruiting

  • Children's Hospital Los Angeles

    Los Angeles, California · Recruiting

  • Stanford University

    Palo Alto, California · Recruiting

  • Children's Hospital Colorado

    Aurora, Colorado · Recruiting

  • Children's National Hospital

    Washington D.C., District of Columbia · Recruiting

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois · Recruiting

  • University of Chicago

    Chicago, Illinois · Recruiting

  • Indiana University

    Indianapolis, Indiana · Recruiting

  • Johns Hopkins Hospital

    Baltimore, Maryland · Recruiting

  • Washington University School of Medicine

    St Louis, Missouri · Recruiting

  • New York University Langone Health

    New York, New York · Recruiting

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio · Recruiting

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania · Recruiting

  • University of Texas Southwestern Medical Center

    Dallas, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.